ISN: Dr. Oliver Distler

International Scleroderma Network

SCLERO.ORG

Scleroderma Experts

*Sclero Forums*

ISN Medical Advisory Board for Sclero.org

Countries/Translations
Arabic	Kannada
Chinese	Korean
Deutsche	Magyarul
Español	Malay
Français	Nederlands
Greek	Polski
Hebrew	Português
Hungarian	Romana
Indonesian	Russian
Italiano	Tamil
Japanese	Turkish

Over 75 virtual volunteers operate the nonprofit International Scleroderma Network. Please let us know how we can help you.

Warm Hugs,
Shelley Ensz,
ISN Founder & President

ISN Representatives

Over 75 virtual volunteers operate the nonprofit International Scleroderma Network (ISN)!
ISN Representatives (Main Page)	How to Volunteer

Dr. Oliver Distler

ISN Medical Advisory Board

My research group is working in the field of molecular biology to identify molecular targets for therapy in systemic sclerosis.

My name is Dr. Oliver Distler and I am serving on the medical advisory board of ISN. I am heading the scleroderma outpatient clinic at the University of Zurich, Switzerland.

Next to my medical duties, my research group is working in the field of molecular biology to identify molecular targets for therapy in systemic sclerosis. This resulted for example in the identification of imatinib (Gleevec) as a potential therapy for scleroderma, which is currently being tested in clinical trials.

How did I get in contact with scleroderma as a medical speciality? This was more than twelve years ago, when the German scleroderma self help group provided research grants for young medical doctors to conduct research in scleroderma. Ever since then I have continued my research on scleroderma.

Department of Rheumatology
University Hospital Zurich
Gloriastr. 25
8091 Zürich
Tel ++41-44-255-2687
FAX: ++41-44-255-4415
Email: oliver-distler@sclero.org

Related Links

Welcome Dr. Oliver Distler: ISN Medical Advisory Board

Dr. Oliver Distler: ISN Medical Advisory Board. I am heading the scleroderma outpatient clinic at the University of Zurich, Switzerland. Next to my medical duties, my research group is working in the field of molecular biology to identify molecular targets for therapy in systemic sclerosis. This resulted for example in the identification of imatinib (Gleevec) as a potential therapy for scleroderma, which is currently being tested in clinical trials. Posted 03-30-08.

Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. A body of evidence has accumulated illustrating that rheumatoid arthritis synovial fibroblasts are active drivers of joint destruction in rheumatoid arthritis. Ulf Müller-Ladner, Caroline Ospelt, Steffen Gay, Oliver Distler, and Thomas Pap, Arthritis Research & Therapy 2007, 9(6): 223. (Also see: Rheumatoid Arthritis and Prof. Ulf Müller-Ladner, MD: ISN Medical Advisory Board )

Keep on Surfing!

Go to Doom, Sheryl

Contact ISN. We are a full-service nonprofit agency.
Email: isn@sclero.org or or post a message in our Sclero Forums ! Shop, Join or Donate Now (Also see: Contact ISN )	International Scleroderma Network (ISN) 7455 France Ave So #266 Edina, MN 55435-4702 USA	Toll Free Hotline in U.S. 1-800-564-7099 Direct Line 952-831-3091 (U.S.)

(We are also known as the Scleroderma from A to Z web site.)
© Copyright 1998-2008 International Scleroderma Network
All Rights Reserved

Donate in Memory

Recent donors or purchasers of ISN and SCLERO.ORG items:

Donate or Shop Now

Sponsor Earl Manns in Chicago Marathon, October 12, 2008! I'm running in honor of my daughter Mya, and in memory of Sherrill Knaggs. (Also see Donate Now and Earl Manns)